BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 36759799)

  • 1. Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy.
    Mafi A; Rezaee M; Hedayati N; Hogan SD; Reiter RJ; Aarabi MH; Asemi Z
    Cell Commun Signal; 2023 Feb; 21(1):33. PubMed ID: 36759799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.
    Gao Y; Xiao X; Zhang C; Yu W; Guo W; Zhang Z; Li Z; Feng X; Hao J; Zhang K; Xiao B; Chen M; Huang W; Xiong S; Wu X; Deng W
    J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 27865009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
    Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
    Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin increases the effect of 5-fluorouracil-based chemotherapy in human colorectal adenocarcinoma cells in vitro.
    Pariente R; Bejarano I; Rodríguez AB; Pariente JA; Espino J
    Mol Cell Biochem; 2018 Mar; 440(1-2):43-51. PubMed ID: 28819759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis induced by aspirin and 5-fluorouracil in human colonic adenocarcinoma cells.
    Ashktorab H; Dawkins FW; Mohamed R; Larbi D; Smoot DT
    Dig Dis Sci; 2005 Jun; 50(6):1025-32. PubMed ID: 15986848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells.
    Sasaki K; Tsuno NH; Sunami E; Tsurita G; Kawai K; Okaji Y; Nishikawa T; Shuno Y; Hongo K; Hiyoshi M; Kaneko M; Kitayama J; Takahashi K; Nagawa H
    BMC Cancer; 2010 Jul; 10():370. PubMed ID: 20630104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways.
    Sivanantham B; Sethuraman S; Krishnan UM
    ACS Comb Sci; 2016 Jan; 18(1):22-35. PubMed ID: 26505786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal prednisolone phosphate potentiates the antitumor activity of liposomal 5-fluorouracil in C26 murine colon carcinoma in vivo.
    Patras L; Sylvester B; Luput L; Sesarman A; Licarete E; Porfire A; Muntean D; Drotar DM; Rusu AD; Nagy AL; Catoi C; Tomuta I; Vlase L; Banciu M; Achim M
    Cancer Biol Ther; 2017 Aug; 18(8):616-626. PubMed ID: 28696813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro additive antitumor effects of dimethoxycurcumin and 5-fluorouracil in colon cancer cells.
    Zhao H; Liu Q; Wang S; Dai F; Cheng X; Cheng X; Chen W; Zhang M; Chen D
    Cancer Med; 2017 Jul; 6(7):1698-1706. PubMed ID: 28573788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells.
    González-Sarrías A; Tomé-Carneiro J; Bellesia A; Tomás-Barberán FA; Espín JC
    Food Funct; 2015 May; 6(5):1460-9. PubMed ID: 25857357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frondoside A Enhances the Anti-Cancer Effects of Oxaliplatin and 5-Fluorouracil on Colon Cancer Cells.
    Attoub S; Arafat K; Khalaf T; Sulaiman S; Iratni R
    Nutrients; 2018 May; 10(5):. PubMed ID: 29724012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of Irinotecan and Melatonin with the Natural Compounds Wogonin and Celastrol for Colon Cancer Treatment.
    Radajewska A; Moreira H; Bęben D; Siwiela O; Szyjka A; Gębczak K; Nowak P; Frąszczak J; Emhemmed F; Muller CD; Barg E
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice.
    Zhang P; Lai ZL; Chen HF; Zhang M; Wang A; Jia T; Sun WQ; Zhu XM; Chen XF; Zhao Z; Zhang J
    J Exp Clin Cancer Res; 2017 Dec; 36(1):190. PubMed ID: 29273065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
    Hao J; Fan W; Li Y; Tang R; Tian C; Yang Q; Zhu T; Diao C; Hu S; Chen M; Guo P; Long Q; Zhang C; Qin G; Yu W; Chen M; Li L; Qin L; Wang J; Zhang X; Ren Y; Zhou P; Zou L; Jiang K; Guo W; Deng W
    J Exp Clin Cancer Res; 2019 Feb; 38(1):48. PubMed ID: 30717768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.
    Reiter RJ; Rosales-Corral SA; Tan DX; Acuna-Castroviejo D; Qin L; Yang SF; Xu K
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer.
    Wang H; Zhang L; Yang X; Jin Y; Pei S; Zhang D; Zhang H; Zhou B; Zhang Y; Lin D
    Oncotarget; 2015 Jun; 6(16):14385-98. PubMed ID: 25965911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Fluorouracil attenuates an oncostatic effect of melatonin on estrogen-sensitive human breast cancer cells (MCF7).
    Furuya Y; Yamamoto K; Kohno N; Ku Y; Saitoh Y
    Cancer Lett; 1994 Jun; 81(1):95-8. PubMed ID: 8019993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Fluorouracil Treatment of CT26 Colon Cancer Is Compromised by Combined Therapy with IMMODIN.
    Demeckova V; Mudronova D; Gancarcikova S; Kubatka P; Kajo K; Kassayova M; Bojkova B; Adamkov M; Solár P
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation.
    Liu K; Wang ZQ; Wang SJ; Liu P; Qin YH; Ma Y; Li XC; Huo ZJ
    Int J Nanomedicine; 2015; 10():6445-54. PubMed ID: 26491300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The validity of melatonin as an oncostatic agent.
    Panzer A; Viljoen M
    J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.